- Comparison of the general characteristics and the hormonal levels between the migraineurs of MM, NMM migraine types and the controls during the follicular and luteal phases using ANOVA and LSD post hoc test.
| Characteristics | Control (n=21) | MM (n=9) | P-value1 | NMM (n=5) | P-value2 |
|---|---|---|---|---|---|
| Mean±SD | Mean±SD | Mean±SD | |||
| Age (years) | 21.83±2.02 | 21.76±2.73 | 0.936 | 22.36±4.48 | 0.596 |
| Body weight (Kg) | 56.59±10.95 | 58.44±7.08 | 0.596 | 65.55±15.68* | 0.027 |
| BMI | 21.78±4.24 | 22.60±2.55 | 0.552 | 25.77±6.53* | 0.013 |
| Follicular phase estrogen (pg/ml) | 11.96±4.68 | 8.88±5.56 | 0.379 | 30.00±19.60** | <0.001 |
| Luteal phase estrogen (pg/ml) | 25.18±13.17 | 21.41±15.36 | 0.506 | 39.79±11.45* | 0.037 |
| Follicular phase progesterone (ng/ml) | 2.90±1.11 | 2.82±1.64 | 0.927 | 4.20±4.77 | 0.232 |
| Luteal phase progesterone (ng/ml) | 8.29±4.56 | 7.36±5.56 | 0.619 | 10.63±2.45 | 0.299 |
| Follicular phase testosterone (ng/ml) | 0.91±0.28 | 1.00±0.32 | 0.549 | 1.14±0.68 | 0.226 |
| Luteal phase testosterone (ng/ml) | 0.83±0.26 | 1.10±0.31* | 0.023 | 0.60±0.22 | 0.089 |
MM - menstrually related, NMM - non-menstrual related, ANOVA - analysis of variance, LSD - least significant difference, BMI - body mass index, SD - standard deviation. P-value1 reflects the level of significance of LSD test comparing MM to the controls, P-value2 reflects the level of significance of LSD test comparing NMM to the controls. * p<0.05, ** p<0.001.